Eicosapentaonoic acid in treatment-resistant depression [2]

Archives of General Psychiatry

Volumn 59, Issue 1, 2002, Pages 91-92

  Puri, B K ^a   Counsell, S J ^a   Richardson, A J ^a   Horrobin, D F ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ICOSAPENTAENOIC ACID; LITHIUM; PAROXETINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; INSOMNIA; LETTER; MALE; SELF ESTEEM; SUICIDAL BEHAVIOR; TREATMENT FAILURE; TREATMENT PLANNING; MAJOR DEPRESSION; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; DEPRESSIVE DISORDER, MAJOR; EICOSAPENTAENOIC ACID; HUMANS; MALE; RECURRENCE; TREATMENT OUTCOME;

EID: 0036006952     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Fish consumption and major depression
2. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients
3. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression
4. Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids
5. Omega 3 fatty acids in bipolar disorder: A preliminary doubleblind, placebo-controlled trial